Company profile
SI-BONE, Inc.
NASDAQ: SIBN · Healthcare · Medical - Devices
#291 of 1,418 Healthcare companies by revenue66th-percentile growth
EA Score
70BFH 76DQ 58GM 78SS 65
v0.1 · 65/100 weight · provisional
↑ growth stability, Piotroski F · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$206.2M
Rev growth YoY (TTM)
+16.8%
Net income (FY)
-$18.9M
Employees
376
as of 2026-08-11
Market cap
$835.5M
as of 2026-08-11
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$200.9M$200.9M2025
Net income-$18.9M-$18.9M2025
Operating income-$22.3M-$22.3M2025
Total assets$238.6M$238.6M2025
Liabilities$61.0M$61.0M2025
Equity$177.5M$177.5M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is SI-BONE, Inc.’s revenue?
SI-BONE, Inc. booked $200.9M in FY2025 revenue, growing 20% year over year — faster than most Healthcare companies we track, at a -9.4% net margin.
Peers · Healthcare
Establishment Labs Holdings Inc.59CCanopy Growth Corporation59CCytek Biosciences, Inc.58CStrata Critical Medical, Inc.60CLifeMD, Inc.73Bbiote Corp.63CNeighbors
Santa Clara →Key facts
CEOLaura A. Francis
SectorHealthcare
IndustryMedical - Devices
HeadquartersSanta Clara, CA
ExchangeNASDAQ: SIBN
Employees376
IPO date2018-10-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.